NO862133L - Amider og deres fremstilling. - Google Patents

Amider og deres fremstilling.

Info

Publication number
NO862133L
NO862133L NO862133A NO862133A NO862133L NO 862133 L NO862133 L NO 862133L NO 862133 A NO862133 A NO 862133A NO 862133 A NO862133 A NO 862133A NO 862133 L NO862133 L NO 862133L
Authority
NO
Norway
Prior art keywords
phenyl
acid
formula
residue
reduced pressure
Prior art date
Application number
NO862133A
Other languages
English (en)
Norwegian (no)
Inventor
Jesus Benavides
Marie-Christine Dubrorucq
Gerard Le Fur
Christian Renault
Original Assignee
Rhone Poulenc Sante
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Sante filed Critical Rhone Poulenc Sante
Publication of NO862133L publication Critical patent/NO862133L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/22—Oxygen atoms attached in position 2 or 4
    • C07D215/227—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/22—Oxygen atoms attached in position 2 or 4
    • C07D215/233—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/36—Sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38—Nitrogen atoms
    • C07D215/42—Nitrogen atoms attached in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/12—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring
    • C07D217/14—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring other than aralkyl radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • C07D217/24—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C07D239/74—Quinazolines; Hydrogenated quinazolines with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached to ring carbon atoms of the hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C07D239/78—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 2
    • C07D239/80—Oxygen atoms
    • C07D239/82—Oxygen atoms with an aryl radical attached in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
    • C07D239/88—Oxygen atoms
    • C07D239/91—Oxygen atoms with aryl or aralkyl radicals attached in position 2 or 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Immunology (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Quinoline Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pyridine Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Hydrogenated Pyridines (AREA)
NO862133A 1985-05-30 1986-05-29 Amider og deres fremstilling. NO862133L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR858508111A FR2582514B1 (fr) 1985-05-30 1985-05-30 Medicaments a base d'amides, nouveaux amides et leur preparation

Publications (1)

Publication Number Publication Date
NO862133L true NO862133L (no) 1986-12-01

Family

ID=9319678

Family Applications (2)

Application Number Title Priority Date Filing Date
NO862134A NO862134L (no) 1985-05-30 1986-05-29 Amidderivater av kinolin samt deres fremstilling.
NO862133A NO862133L (no) 1985-05-30 1986-05-29 Amider og deres fremstilling.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
NO862134A NO862134L (no) 1985-05-30 1986-05-29 Amidderivater av kinolin samt deres fremstilling.

Country Status (20)

Country Link
US (3) US4728647A (hu)
EP (2) EP0205375B1 (hu)
JP (2) JPS625946A (hu)
AT (2) ATE40689T1 (hu)
AU (2) AU579472B2 (hu)
CA (2) CA1264160A (hu)
DE (2) DE3666813D1 (hu)
DK (2) DK252286A (hu)
ES (7) ES8704732A1 (hu)
FR (1) FR2582514B1 (hu)
GR (2) GR861369B (hu)
HU (2) HU195642B (hu)
IL (2) IL78968A (hu)
MA (2) MA20697A1 (hu)
NO (2) NO862134L (hu)
NZ (2) NZ216331A (hu)
PT (2) PT82674B (hu)
SU (7) SU1440342A3 (hu)
TN (2) TNSN86081A1 (hu)
ZA (2) ZA863992B (hu)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4876346A (en) * 1985-05-02 1989-10-24 American Home Products Corporation Quinoline compounds
FR2582514B1 (fr) * 1985-05-30 1988-02-19 Rhone Poulenc Sante Medicaments a base d'amides, nouveaux amides et leur preparation
HU199424B (en) * 1987-04-24 1990-02-28 Egyt Gyogyszervegyeszeti Gyar Process for producing quinoline thioethers and pharmaceutical compositions comprising such compounds
HU199423B (en) * 1987-04-24 1990-02-28 Egyt Gyogyszervegyeszeti Gyar Process for producing 3-amino-4-/ethylthio/-quinoline and pharmaceutical compositions comprising such compounds
GB8726735D0 (en) * 1987-11-14 1987-12-16 Wellcome Found Pesticidal compounds
DE68917024D1 (de) * 1988-05-24 1994-09-01 Kirin Brewery 4(1H)-Chinolonderivate.
FR2636327A1 (fr) * 1988-09-13 1990-03-16 Rhone Poulenc Sante Derives de quinoleine, leurs procedes de preparation et les medicaments les contenant
JP2669905B2 (ja) * 1989-09-01 1997-10-29 ファナック株式会社 リレーの溶着検出方法
FR2665159B1 (fr) * 1990-07-24 1992-11-13 Rhone Poulenc Sante Nouveaux derives de la pyridine et de la quinoleine, leur preparation et les compositions pharmaceutiques qui les contiennent.
NO932130L (no) * 1992-06-19 1993-12-20 Lilly Co Eli Hemmere av HIV-protease som er nyttige for behandling av AIDS
JP3408300B2 (ja) * 1993-11-10 2003-05-19 シチズン時計株式会社 プリンタ
DE4420337A1 (de) * 1994-06-10 1995-12-14 Bayer Ag N-Heterocyclyl-heteroaryloxyacetamide
US5658902A (en) * 1994-12-22 1997-08-19 Warner-Lambert Company Quinazolines as inhibitors of endothelin converting enzyme
IL117659A (en) * 1995-04-13 2000-12-06 Dainippon Pharmaceutical Co Substituted 2-phenyl pyrimidino amino acetamide derivative process for preparing the same and a pharmaceutical composition containing same
US5648448A (en) * 1995-06-06 1997-07-15 Hitachi Chemical Company, Ltd. Method of preparation of polyquinolines
US5776946A (en) * 1995-08-28 1998-07-07 Mcgeer; Patrick L. Peripheral benzodiazepine receptor ligands as antiinflammatory agents
FR2750427B1 (fr) * 1996-06-28 1998-08-07 Synthelabo Derives de 1-oxo-1, 2-dihydroisoquinoleine-4-propanamide, leur preparation et leur application en therapeutique
AU7474998A (en) * 1997-05-07 1998-11-27 Emory University Haloisoquinoline carboxamide
ZA9810490B (en) 1997-12-03 1999-05-20 Dainippon Pharmaceutical Co 2-Aryl-8-oxodihydropurine derivative process for the preparation thereof pharmaceutical composition containing the same and intermediate therefor
FR2778564B1 (fr) * 1998-05-13 2001-07-13 Sanofi Sa Utilisation de composes reduisant l'apoptose
WO1999058117A1 (fr) * 1998-05-13 1999-11-18 Sanofi-Synthelabo Utilisation de composes reduisant l'apoptose
FR2779963A1 (fr) 1998-06-22 1999-12-24 Centre Nat Rech Scient Utilisation d'un compose possedant une affinite pour le recepteur mitochondrial des benzodiazepines en therapie du cancer
ATE333281T1 (de) 1998-12-18 2006-08-15 Scios Inc Agonisten und antagonisten von benzodiazepinrezeptoren des peripheren typs
US6297256B1 (en) * 1999-06-15 2001-10-02 Neurogen Corporation Aryl and heteroaryl substituted pyridino derivatives GABA brain receptor ligands
AR026748A1 (es) * 1999-12-08 2003-02-26 Vertex Pharma Un compuesto inhibidor de caspasas, una composicion farmaceutica que lo comprende, un metodo para la sintesis del mismo y un compuesto intermediario paradicha sintesis
EP1110552A1 (en) * 1999-12-22 2001-06-27 Aventis Pharma S.A. Use of a compound with affinity for the mitochondrial benzodiazepine receptor in cancer therapy
US6828329B2 (en) 2000-06-26 2004-12-07 Neurogen Corporation Aryl fused substituted 4-oxy-pyridines
AU2003248758A1 (en) * 2002-06-28 2004-01-19 Vertex Pharmaceuticals Incorporated Caspase inhibitors and uses thereof
TW200500343A (en) * 2002-12-20 2005-01-01 Vertex Pharma Caspase inhibitors and uses thereof
DE60335028D1 (de) * 2002-12-23 2010-12-30 Icagen Inc Quinazolinone als kaliumkanalmodulatoren
PE20050159A1 (es) * 2003-05-27 2005-04-19 Vertex Pharma Derivados de acido 3-[2-(3-amino-2-oxo-2h-piridin-1-il)-acetilamino]-4-oxo-pentanoico como inhibidores de caspasa
US7423176B2 (en) * 2004-04-13 2008-09-09 Cephalon, Inc. Bicyclic aromatic sulfinyl derivatives
EP1889837A1 (en) * 2006-07-10 2008-02-20 Pharmeste S.r.l. VR1 vanilloid receptor antagonists with a iononic substructure
ES2388454T3 (es) * 2007-03-22 2012-10-15 Astrazeneca Ab Derivados de quinolina para el tratamiento de enfermedades inflamatorias
US8382751B2 (en) * 2009-09-10 2013-02-26 Covidien Lp System and method for power supply noise reduction

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR964545A (hu) * 1947-04-11 1950-08-18
US2568037A (en) * 1947-10-24 1951-09-18 Sterling Drug Inc Tertiary-aminoalkyl esters and amides of 4-quinolylmercaptoalkanoic acids and their preparation
US2785165A (en) * 1953-12-22 1957-03-12 Abbott Lab Preparation of 4-aminoquinoline
GB1013224A (en) * 1962-06-21 1965-12-15 Ici Ltd Heterocyclic aminoethanols
GB1064252A (en) * 1963-09-19 1967-04-05 Ici Ltd Amides and pharmaceutical compositions containing them
IL26022A (en) * 1966-06-23 1971-06-23 Haber R Nitrofuryl quinoline derivatives
GB1177548A (en) * 1967-11-28 1970-01-14 Ici Ltd Phenoxy-and Anilino-Alkanoic Acid Amides
US3595861A (en) * 1967-12-08 1971-07-27 American Home Prod Novel synthesis of 2-quinazolinepropionic acids and derivatives
FR8411M (hu) * 1968-12-31 1971-03-31
DE2361438C3 (de) * 1973-12-10 1979-12-13 Hoechst Ag, 6000 Frankfurt 4-Hydroxychinoün- und 4-Hydroxytetrahydrochinolin-N^N-dimethylcarbamate, Verfahren zu ihrer Herstellung und diese enthaltende insektizide Mittel
DE2411662A1 (de) 1974-03-12 1975-09-25 Lechler Elring Dichtungswerke Vorrichtung zum einseitigen anheben und lenkbarmachen einer palette insbesondere einer rollpalette
GB1574019A (en) * 1977-01-14 1980-09-03 Joullie International Sa Therapeutically useful 3,4,5-trimethoxybenzene derivatives
FR2471981A1 (fr) * 1979-12-21 1981-06-26 Pharmindustrie Nouveaux derives de la (piperidyl-4)-2 (quinolyl-4)-1 ethanone, produits intermediaires et procedes pour leur preparation, et leur utilisation comme medicaments
FR2485014A1 (fr) * 1980-06-20 1981-12-24 Pharmindustrie Nouveaux derives de (quinolyl-2, -3 ou -4)-1 (piperidyl ou pyrrolidinyl-2 ou -3)-2 ou -3 ethanone ou propanone, procedes pour leur preparation, et leur utilisation comme medicaments
FR2525595A1 (fr) * 1982-04-27 1983-10-28 Pharmuka Lab Nouveaux derives d'arene et d'heteroarenecarboxamides et leur utilisation comme medicaments
FR2538388B1 (fr) * 1982-12-24 1985-06-21 Pharmuka Lab Nouveaux derives de naphtalene- ou azanaphtalenecarboxamide, leurs procedes de preparation et leur utilisation comme medicaments
NZ209710A (en) * 1983-09-29 1988-02-12 Akzo Nv Quinazoline and isoquinoline derivatives and pharmaceutical and veterinary compositions containing such
FR2582514B1 (fr) * 1985-05-30 1988-02-19 Rhone Poulenc Sante Medicaments a base d'amides, nouveaux amides et leur preparation

Also Published As

Publication number Publication date
DK252286D0 (da) 1986-05-29
US4788204A (en) 1988-11-29
DE3662045D1 (en) 1989-03-16
SU1508957A3 (ru) 1989-09-15
US4728647A (en) 1988-03-01
ES8705227A1 (es) 1987-05-01
NZ216330A (en) 1989-04-26
ES8704732A1 (es) 1987-04-16
EP0205375A1 (fr) 1986-12-17
ES8705225A1 (es) 1987-05-01
HU195642B (en) 1988-06-28
IL78969A0 (en) 1986-09-30
PT82673B (pt) 1988-08-17
MA20696A1 (fr) 1986-12-31
MA20697A1 (fr) 1986-12-31
EP0210084A1 (fr) 1987-01-28
GR861368B (en) 1986-09-29
SU1614759A3 (ru) 1990-12-15
IL78968A0 (en) 1986-09-30
SU1470182A3 (ru) 1989-03-30
US4788199A (en) 1988-11-29
ES557170A0 (es) 1987-05-01
ES8704731A1 (es) 1987-04-16
PT82674A (fr) 1986-06-01
ES557169A0 (es) 1987-05-01
IL78969A (en) 1989-07-31
ES557168A0 (es) 1987-05-01
AU5803186A (en) 1986-12-04
ES8705226A1 (es) 1987-05-01
CA1251206A (fr) 1989-03-14
AU5803086A (en) 1986-12-04
CA1264160A (fr) 1990-01-02
ZA863993B (en) 1987-01-28
HUT42071A (en) 1987-06-29
HU195641B (en) 1988-06-28
SU1440342A3 (ru) 1988-11-23
EP0210084B1 (fr) 1989-02-08
EP0205375B1 (fr) 1989-11-08
ES8800660A1 (es) 1987-11-16
NZ216331A (en) 1989-04-26
ES557167A0 (es) 1987-11-16
JPS6264A (ja) 1987-01-06
ATE40689T1 (de) 1989-02-15
AU579473B2 (en) 1988-11-24
IL78968A (en) 1989-07-31
NO862134L (no) 1986-12-01
FR2582514B1 (fr) 1988-02-19
HUT42072A (en) 1987-06-29
GR861369B (en) 1986-09-29
JPS625946A (ja) 1987-01-12
TNSN86081A1 (fr) 1990-01-01
ES555558A0 (es) 1987-04-16
AU579472B2 (en) 1988-11-24
DK252386D0 (da) 1986-05-29
ES555557A0 (es) 1987-04-16
DE3666813D1 (en) 1989-12-14
SU1544186A3 (ru) 1990-02-15
ATE47840T1 (de) 1989-11-15
SU1470183A3 (ru) 1989-03-30
ES557166A0 (es) 1987-05-01
SU1537135A3 (ru) 1990-01-15
DK252286A (da) 1986-12-01
TNSN86080A1 (fr) 1990-01-01
PT82674B (pt) 1988-08-17
ZA863992B (en) 1987-01-28
FR2582514A1 (fr) 1986-12-05
DK252386A (da) 1986-12-01
ES8705228A1 (es) 1987-05-01
PT82673A (fr) 1986-06-01

Similar Documents

Publication Publication Date Title
NO862133L (no) Amider og deres fremstilling.
EA009647B1 (ru) Арилсульфонамидные соединения и их применение для лечения ожирения и диабета типа ii
FR2538388A1 (fr) Nouveaux derives de naphtalene- ou azanaphtalenecarboxamide, leurs procedes de preparation et leur utilisation comme medicaments
Cale Jr et al. Benzo-and pyrido-1, 4-oxazepin-5-ones and-thiones: synthesis and structure-activity relationships of a new series of H1-antihistamines
JP2020533328A (ja) ベンゼン縮合複素環誘導体およびその医薬組成物
KR0126674B1 (ko) 아포빈카민산 유도체
AU644296B2 (en) 2-(1-piperidyl)ethanol derivatives, their preparation and their therapeutic application
CH617934A5 (hu)
EP0015615B1 (en) Phenyl piperazine derivatives, their preparation and antiagressive medicines containing them
EP0064445B1 (fr) Dialcoxy (2,4) benzènesulfonamides N-substitués
EP0119107B1 (fr) Nouveaux dérivés du bicyclo(4.2.0)octatriène-1,3,5, leur préparation et leur application en thérapeutique
EP0511072A1 (fr) Dérivés de 2-aminopyrimidine-4-carboxamide, leur préparation et leur application en thérapeutique
US4963680A (en) Piperazine derivatives and their preparation process
Unangst et al. 2‐Indolyl ketone synthesis
CH633552A5 (fr) Procede de preparation de nouveaux benzothiophenes.
JP2001521498A (ja) Ｏ−（３−アミノ−２−ヒドロキシ−プロピル）−ヒドロキシミック酸ハロゲン化物の製造方法
EP0374054A1 (fr) Composés dérivés de l'indane, leur procédé et les intermédiaires de préparation, leur application comme médicaments et les compositions pharmaceutiques les renfermant
SU880251A3 (ru) Способ получени производных тиохромана или их солей
CA2306428C (fr) Derives de la 3-oxo-2(h)-1,2,4 - triazine en tant que ligands des recepteurs 5ht1a
EP0220104B1 (fr) Dérivés d'amino-5 pentanenitrile, leurs procédés de préparation et les compositions pharmaceutiques qui les contiennent
JPS6116264B2 (hu)
US6063784A (en) Heteroaryloxyethylamines, method of preparation, application as medicine and pharmaceutical compositions containing them
WO2014081025A1 (ja) ３，４－ジフルオロ－２－（２－フルオロ－４－ヨード－フェニルアミノ）－n－（２－ヒドロキシ－エトキシ）－５－（３－オキソ－[１，２]オキサジナン－２－イルメチル）－ベンズアミドの新規結晶形
CN117304065A (zh) 芳基环丙基类化合物制备方法和用途
FR2663026A1 (fr) Derives de [(1-arylpyrrolidin-2-yl) methyl] piperazine, leur preparation et leur application en therapeutique.